Comparison of Th1 and Th2 response in the blood of tuberculous patients and healthy contacts

Pneumonologia i Alergologia Polska

Volumn 77, Issue 5, 2009, Pages 446-452

  Winek, Jolanta ^a   Demkow, Urszula ^b   Zakrzewska, Ewa Rowińska ^a   Szołkowska, Małgorzata ^a   Filewska, Małgorzata ^a   Jagodziński, Jacek ^c   Roszkowski Śliz, Kazimierz ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Mazovien Center of Tuberculosis and Lung Diseases   (Poland)

Author keywords

Antimycobacterial antibodies; IFN gamma; IL 2; Th 1; Th2 response in tuberculosis

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HOSPITALIZATION; HUMAN; IMMUNOLOGY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; POLAND; REFERENCE VALUE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MYCOBACTERIUM TUBERCULOSIS; POLAND; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 74049085525     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Newport M.J., Nejentsev S. Genetics of susceptibility to tuberculosis in humans. Monaldi Arch. Chest Dis. 2004; 61: 102-111.
2. Morosini M., Meloni F., Marone Bianco A. et al. The assessment of IFN-g and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2003; 7: 994-1000.
3. Garcia M., Vargas J.A., Castejon R. et al. Flow-cytometric assessment of lymphocyte cytokine production in tuberculosis. Tuberculosis 2002; 82: 37-41.
4. Jo E.K., Park J.K., Dockrell H.M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis. 2003; 16: 205-210.
5. Demissie A., Abebe M., Aseffa A. et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist Il-4D2. J. Immunol. 2004; 172: 6938-6943.
6. Dheda K., Chang J.S., Breen R.A.M. et al. In vivo and in vitro studies of a novel cytokine interleukin 4D2, in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2005; 172: 501-508.
7. Dheda K., Chang J.S., Huggett J.F. et al. The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA enconding the antagonistic splice variant, IL-4D2, is not. Tuberculosis 2007; 87: 237-241.
8. ElsDsser-Beile U., Von Kleist S., Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 1991; 139: 191-195.
9. Elliot A.M., Hurst T.J., Balyeku M.N., i wsp. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in a epidemiological study. Int. J. Tuberc. Lung Dis. 1999; 3: 239-247.
10. Morosini M., Meloni F., Uccelli M. et al. Ex vivo evaluation of PPD-specific IFN-g or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis. Int. J. Tuberc. Lung Dis. 2005; 9: 753-759.
11. De Castro Cunha R.M., Kallas E.G., Rodrugues D.S. et al. Interferon- g and tumor nercosis factor-a production by CD4+T and CD8+ T lymphocytes in AIDS patients with tuberculosis. Clin. Exp. Immunol. 2005; 140: 491-497.
12. Toossi Z., Kleinhenz M.E., Ellner J.J. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med. 1986; 163: 1162-1172.
13. Winek J., Rowinska-Zakrzewska E., Demkow U. et al. Interferon gamma production in the course of Mycobacterium tuberculosis infection. J. Physiol. Pharmacol. 2008, 59 (suppl. 6): 751-759.
14. Hirsch C.S., Toossi Z., Othieno C. et al. Depressed T-cell interferon- g responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 1999; 180: 2069-2073.
15. Vankayalapati R., Wizel B., Weis S.E. et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin. Infect. Dis. 2003; 36: 24-28.
16. Sanchez F.O., Rodriguez J.I., Agudelo G. Garcia L.F. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 1994; 62: 5673-5678.
17. Dlugovitzky D., Bay M.L., Rateni L. et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin. Exp. Immunol. 2000; 122: 343-349.
18. Fortes A., Pereira K., Antas P.R.Z. et al. Detection of in vitro interferon-g and serum tumour necrosis factor-a in multidrug--resistant tuberculosis patients. Clin. Exp. Immunol. 2005; 141: 541-548.
19. Ferrand R.A., Bothamley G.H., Whelen A., Dockrell H.M. Interferon- gamma responses to ESAT-6 in tuberculosis patients early into and after antituberculosis treatment. Int. J. Tuberc. Lung Dis. 2005; 9: 1034-1039.
20. Ulrichs T., Anding P., Kaufmann S.H.E., Munk M.E. Numbers of IFNg-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int. J. Tuberc. Lung. Dis. 2000; 4: 1181-1183.
21. Verbon A., Juffermans N., Van Deventer S.J.H. et al. Serum concentrations of cytokine in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 1999; 115: 110-113.
22. Seah G.T., Scott G.M., Rook G.A.W. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 2000; 181: 385-389.